StarTric develops a minimally invasive device addressing Tricuspid Regurgitation (TR).
StarTric has 1 recorded funding round in the Tech.eu database (amounts undisclosed). Based in Milan, Italy; active in Healthtech. Data as of 6 Aug 2026.
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2024-07-09 | Seed | — |
| Business Angels,Growth Engine ,NLC Health Impact Fund |
| View deal → |
